BLT 0.00% 15.5¢ benitec biopharma limited

Panno response on Tribetarna Trial

  1. 2,059 Posts.
    lightbulb Created with Sketch. 35
    Panno response about Tribetarna trial starting ....

    Author’s reply »The role of tubulin in NSCLC is still being investigated by the team. The work published late last year

    has identified tubulin's mode of action in NSCLC. This is a significant step in understanding the safety profile of Tribetarna and increases the chances of the FDA approving an IND. Assuming that the biodistribution studies are also close to completion, then the IND application should not be too far away. The only drawback that I can envisage is the biodistribution study MAY throw up some new data that needs additional work to prove the safety profile is complete. If this were to be the case, then we would need more information before the impact of any such findings could be assessed.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist
(20min delay)
Mkt cap $39.83M
Open High Low Value Volume
15.5¢ 15.5¢ 15.5¢ $6.758K 43.60K

Buyers (Bids)

No. Vol. Price($)
2 125679 15.5¢

Sellers (Offers)

Price($) Vol. No.
16.0¢ 21999 1
Last update - 16.10pm 15/10/2018 (20 minute delay) ?
0.00 ( 0.00 %)
Open High   Low Volume
15.5¢ 15.5¢   15.5¢ 31146
Last updated 15.59pm 15/10/2018 (live) ?
BLT (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.